James MT - Search Results

1

Higher potency statins and the risk of new diabetes: multicentre, observational study of administrative databases.

Dormuth CR, Filion KB, Paterson JM, James MT, Teare GF, Raymond CB, Rahme E, Tamim H, Lipscombe L; Canadian Network for Observational Drug Effect Studies Investigators. Dormuth CR, et al. Among authors: james mt. BMJ. 2014 May 29;348:g3244. doi: 10.1136/bmj.g3244. BMJ. 2014. PMID: 24874977 Free PMC article.

2

Meta-analysis: antibiotics for prophylaxis against hemodialysis catheter-related infections.

James MT, Conley J, Tonelli M, Manns BJ, MacRae J, Hemmelgarn BR; Alberta Kidney Disease Network. James MT, et al. Ann Intern Med. 2008 Apr 15;148(8):596-605. doi: 10.7326/0003-4819-148-8-200804150-00004. Ann Intern Med. 2008. PMID: 18413621

3

Risk of bloodstream infection in patients with chronic kidney disease not treated with dialysis.

James MT, Laupland KB, Tonelli M, Manns BJ, Culleton BF, Hemmelgarn BR; Alberta Kidney Disease Network. James MT, et al. Arch Intern Med. 2008 Nov 24;168(21):2333-9. doi: 10.1001/archinte.168.21.2333. Arch Intern Med. 2008. PMID: 19029498

4

Derivation and internal validation of an equation for albumin-adjusted calcium.

James MT, Zhang J, Lyon AW, Hemmelgarn BR. James MT, et al. BMC Clin Pathol. 2008 Nov 27;8:12. doi: 10.1186/1472-6890-8-12. BMC Clin Pathol. 2008. PMID: 19038049 Free PMC article.

5

CKD and risk of hospitalization and death with pneumonia.

James MT, Quan H, Tonelli M, Manns BJ, Faris P, Laupland KB, Hemmelgarn BR; Alberta Kidney Disease Network. James MT, et al. Am J Kidney Dis. 2009 Jul;54(1):24-32. doi: 10.1053/j.ajkd.2009.04.005. Epub 2009 May 17. Am J Kidney Dis. 2009. PMID: 19447535

6

What's next after fistula first: is an arteriovenous graft or central venous catheter preferable when an arteriovenous fistula is not possible?

James MT, Manns BJ, Hemmelgarn BR, Ravani P; Alberta Kidney Disease Network. James MT, et al. Semin Dial. 2009 Sep-Oct;22(5):539-44. doi: 10.1111/j.1525-139X.2009.00633.x. Epub 2009 Sep 9. Semin Dial. 2009. PMID: 19744149 Review.

7

Ascorbic acid for anemia management in hemodialysis patients: a systematic review and meta-analysis.

Deved V, Poyah P, James MT, Tonelli M, Manns BJ, Walsh M, Hemmelgarn BR; Alberta Kidney Disease Network. Deved V, et al. Among authors: james mt. Am J Kidney Dis. 2009 Dec;54(6):1089-97. doi: 10.1053/j.ajkd.2009.06.040. Epub 2009 Sep 23. Am J Kidney Dis. 2009. PMID: 19783342 Review.

8

Relation between kidney function, proteinuria, and adverse outcomes.

Hemmelgarn BR, Manns BJ, Lloyd A, James MT, Klarenbach S, Quinn RR, Wiebe N, Tonelli M; Alberta Kidney Disease Network. Hemmelgarn BR, et al. Among authors: james mt. JAMA. 2010 Feb 3;303(5):423-9. doi: 10.1001/jama.2010.39. JAMA. 2010. PMID: 20124537

9

Cardiovascular effects of angiotensin converting enzyme inhibition or angiotensin receptor blockade in hemodialysis: a meta-analysis.

Tai DJ, Lim TW, James MT, Manns BJ, Tonelli M, Hemmelgarn BR; Alberta Kidney Disease Network. Tai DJ, et al. Among authors: james mt. Clin J Am Soc Nephrol. 2010 Apr;5(4):623-30. doi: 10.2215/CJN.07831109. Epub 2010 Feb 4. Clin J Am Soc Nephrol. 2010. PMID: 20133488 Free PMC article. Review.

10

Nephrology visits and health care resource use before and after reporting estimated glomerular filtration rate.

Hemmelgarn BR, Zhang J, Manns BJ, James MT, Quinn RR, Ravani P, Klarenbach SW, Culleton BF, Krause R, Thorlacius L, Jain AK, Tonelli M; Alberta Kidney Disease Network. Hemmelgarn BR, et al. Among authors: james mt. JAMA. 2010 Mar 24;303(12):1151-8. doi: 10.1001/jama.2010.303. JAMA. 2010. PMID: 20332400

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

251 results

Search Page

Filters